//
2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: Insights from the randomized GLOBAL LEADERS trial
Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy JACC Guideline Comparison: JACC State-of-the-Art Review
Dual Antiplatelet TherapyIs It Time to Cut the Cord With Aspirin?
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry)